Akademisyen
PINAR OBAKAN YERLİKAYA
PROFESÖR
İSTANBUL MEDENİYET ÜNİVERSİTESİ MÜHENDİSLİK VE DOĞA BİLİMLERİ FAKÜLTESİ MOLEKÜLER BİYOLOJİ VE GENETİK BÖLÜMÜ
- Ana Dal Fen Bilimleri ve Matematik Temel Alanı
- Yan Dal Biyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 88
- Proje 0
- Kitap 5
- Bildiri 127
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
22
Q2
39
Q3
5
Q4
7
WoS (JCR)
Q1
13
Q2
16
Q3
29
Q4
11
TR Index
9
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
3
Ort. yüzdelik
60.4%
Üst %1 payı
0.0%
Üst %10 payı
4.8%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Effects of α‐Lipoic Acid, vitamin E, and Selenium Combination on Inflammation‐Independent ROS‐Induced Damage in Kidney Tissue of Diabetic Mice YÖKSİS SJR Q1 JCR Q2 OpenAlex 17.0%
- 2025 Targeting Methionine Metabolism Reveals AMPK-SAMTOR Signaling as a Therapeutic Vulnerability in Prostate Cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.4%
- 2025 Combination treatment with epibrassinolide overcomes tamoxifen resistance in breast cancer cells via endoplasmic reticulum stress induction. YÖKSİS SJR Q2 JCR Q3 OpenAlex 29.6%
- 2025 In silico multitargeted molecular docking study of interacting partners of epibrassinolide in cancer cells and in vitro evaluation of cell death mechanisms associated with these partners YÖKSİS SJR Q2 JCR Q3 OpenAlex 12.2%
- 2025 Synthesis and Characterization of Ag Doped CuO Nanoparticles with Different Sizes and Investigation of Their Anticancer Activity YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 90.2%
- 2025 Roles of microRNAs carried by exosomes in glioblastoma microenvironment YÖKSİS SJR Q4 JCR Q4 OpenAlex 57.2%
- 2024 Recent in vitro models and tissue engineering strategies to study glioblastoma YÖKSİS TR Index SJR Q3 OpenAlex 52.4%
- 2023 Epibrassinolide impaired colon tumor progression and induced autophagy in SCID mouse xenograft model via acting on cell cycle progression without affecting endoplasmic reticulum stress observed in vitro YÖKSİS SJR Q1 JCR Q2 OpenAlex 67.2%
- 2023 The Use of Plant Steroids in Viral Disease Treatments: Current Status and Future Perspectives YÖKSİS SJR Q4 JCR Q4 OpenAlex 88.2%
- 2022 Circulating microRNA expression profiles to identify a potential link between prostate cancer and obesity YÖKSİS SJR Q4 JCR Q4 OpenAlex 40.3%
- 2022 The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 12.7%
- 2022 Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 70.0%
- 2022 Synthesis and characterization of novel ssDNA X-aptamers targeting Growth Hormone Releasing Hormone (GHRH) YÖKSİS SJR Q1 JCR Q1 OpenAlex 56.2%
- 2022 Epibrassinolide Triggers Apoptotic Cell Death in SK-N-AS Neuroblastoma Cells by Targeting GSK3β in a ROS Generation-Dependent Way YÖKSİS SJR Q4 JCR Q4 OpenAlex 48.7%
- 2021 In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast Cancer Cells YÖKSİS SJR Q1 JCR Q1 OpenAlex 46.8%
- 2021 miR27a, a fine-tuning molecule, interacts with growth hormone (GH) signaling and ornithine decarboxylase (ODC) via targeting STAT5. YÖKSİS SJR Q2 JCR Q3 OpenAlex 41.8%
- 2021 Palbociclib negatively regulates fatty acid synthesis due to upregulation of AMPK alpha and miR-33a levels to increase apoptosis in Panc-1 and MiaPaCa-2 cells YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.7%
- 2021 Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells YÖKSİS SJR Q2 JCR Q4 OpenAlex 76.6%
- 2021 Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine YÖKSİS SJR Q2 JCR Q3 OpenAlex 55.5%
- 2021 AMPK Is the Crucial Target for the CDK4/6 Inhibitors Mediated Therapeutic Responses in PANC-1 and MIA PaCa-2 Pancreatic Cancer Cell Lines YÖKSİS SJR Q1 OpenAlex 59.5%